Where does your iron go? MRI study follows the trail

NCT ID NCT05609318

Recruiting now Knowledge-focused Sponsor: University of Oxford Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study uses MRI scans to track where iron travels in the body after an intravenous iron infusion. Researchers will monitor 12 iron-deficient adults over hours, days, and weeks to see how iron is absorbed by organs like the heart, liver, and spleen. The goal is to better understand iron distribution, not to test a new treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Ferric carboxymaltose (Ferinject) intravenous infusion
What this could lead to: If successful, this could help doctors better understand how iron is stored in the body after treatment, potentially improving future iron deficiency therapies.
What could go wrong: This is a very small observational study with only 12 participants, so results may not apply to everyone. It is not testing a new treatment, only tracking iron movement.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IRON-DEFICIENCY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

iron deficiency anemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

IRON-DEFICIENCY

Contacts and locations

Locations

Oxford Centre for Clinical Magnetic Resonance Research (OCMR)
RECRUITING

Oxford, Oxfordshire, OX3 9DU, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.